Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Inspecs Group plc on the acquisition of Ego Eyewear Limited.
Mandate

Vinge advises Inspecs Group plc on the acquisition of Ego Eyewear Limited.

January 07, 2022 M&A

Vinge advises Inspecs Group plc on the acquisition of Ego Eyewear Limited.

For more information about the transaction please see the client’s press release.


The Vinge team advising Inspecs Group plc includes partner Christina Kokko, counsel Ulrich Ziche, associates Nina Gransäter, Robin Fagerström, Ebba Nyberg, Isabell Nielsen, Veronika Garemark, Rebecka Målquist, Ulf Pyk and paralegals Jessica Henning and Sara Dahlros Sköld. Counsel Maria Schultzberg and associate Karl-Gustaw Tobola are advising on the tax issues of the transaction.


Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025